Caldera Therapeutics
Updated: March 05, 2026
CEO - Praveen Tipirneni
Country: USA | Funding: $112.5M (+)
Founded: 2025
Website: https://www.calderatx.com/
Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).
Founded: 2025
Website: https://www.calderatx.com/
Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).
